Association of eNOS and MCP-1 Genetic Variants with Type 2 Diabetes and Diabetic Nephropathy Susceptibility: A Case-Control and Meta-Analysis Study
- PMID: 33609191
- PMCID: PMC7896546
- DOI: 10.1007/s10528-021-10041-2
Association of eNOS and MCP-1 Genetic Variants with Type 2 Diabetes and Diabetic Nephropathy Susceptibility: A Case-Control and Meta-Analysis Study
Abstract
Type 2 diabetes (T2D) and its secondary complications result from the complex interplay of genetic and environmental factors. To understand the role of these factors on disease susceptibility, the present study was conducted to assess the association of eNOS and MCP-1 variants with T2D and diabetic nephropathy (DN) in two ethnically and geographically different cohorts from North India. A total of 1313 subjects from two cohorts were genotyped for eNOS (rs2070744, rs869109213 and rs1799983) and MCP-1 (rs1024611 and rs3917887) variants. Cohort-I (Punjab) comprised 461 T2D cases (204 T2D with DN and 257 T2D without DN) and 315 healthy controls. Cohort-II (Jammu and Kashmir) included 337 T2D (150 T2D with DN and 187 T2D without DN) and 200 controls. Allele, genotype and haplotype frequencies were compared among the studied participants, and phenotype-genotype interactions were determined. Meta-analysis was performed to investigate the association between the selected variants and disease susceptibility. All three eNOS variants were associated with 1.5-4.0-fold risk of DN in both cohorts. MCP-1 rs1024611 conferred twofold risk towards DN progression in cohort-II, while rs3917887 provided twofold risk for both T2D and DN in both cohorts. eNOS and MCP-1 haplotypes conferred risk for T2D and DN susceptibility. Phenotype-genotype interactions showed significant associations between the studied variants and anthropometric and biochemical parameters. In meta-analysis, all eNOS variants conferred risk towards DN progression, whereas no significant association was observed for MCP-1 rs1024611. We show evidences for an association of eNOS and MCP-1 variants with T2D and DN susceptibility.
Keywords: Diabetic nephropathy; Genetic variant; MCP-1; Type 2 diabetes; eNOS.
Conflict of interest statement
The authors report no conflicts of interest. The authors alone are responsible for the content and writing of this article.
Figures



Similar articles
-
Association of endothelial nitric oxide synthase Glu298Asp, 4b/a, and -786T>C gene variants with diabetic nephropathy.J Diabetes Complications. 2008 Sep-Oct;22(5):331-8. doi: 10.1016/j.jdiacomp.2007.11.011. Epub 2008 Apr 16. J Diabetes Complications. 2008. PMID: 18413207
-
Association between the MCP-1 -2518 A > G (rs1024611) polymorphism and susceptibility to type 2 diabetes mellitus and diabetic nephropathy: a meta-analysis.BMC Endocr Disord. 2023 Dec 4;23(1):267. doi: 10.1186/s12902-023-01514-z. BMC Endocr Disord. 2023. PMID: 38049786 Free PMC article.
-
Monocyte chemoattractant protein-1 (MCP-1) g.-2518A>G polymorphism and susceptibility to type 2 diabetes (T2D) and end stage renal disease (ESRD) in the North-West Indian population of Punjab.Ann Hum Biol. 2015;42(3):276-82. doi: 10.3109/03014460.2014.941932. Epub 2014 Aug 26. Ann Hum Biol. 2015. PMID: 25154422
-
Association between endothelial nitric oxide synthase Glu298Asp gene polymorphism and diabetic nephropathy susceptibility.Ren Fail. 2013;35(1):173-8. doi: 10.3109/0886022X.2012.734939. Epub 2012 Nov 1. Ren Fail. 2013. PMID: 23113598 Review.
-
Role of endothelial nitric oxide synthase in diabetic nephropathy: lessons from diabetic eNOS knockout mice.J Diabetes Res. 2014;2014:590541. doi: 10.1155/2014/590541. Epub 2014 Oct 13. J Diabetes Res. 2014. PMID: 25371905 Free PMC article. Review.
Cited by
-
Evaluation of Association Studies and Meta-Analyses of eNOS Polymorphisms in Type 2 Diabetes Mellitus Risk.Front Genet. 2022 Jun 27;13:887415. doi: 10.3389/fgene.2022.887415. eCollection 2022. Front Genet. 2022. PMID: 35832187 Free PMC article.
-
Recent Progress in Genetics and Epigenetics Research on Diabetic Nephropathy in Malaysia.J Diabetes Res. 2023 May 5;2023:9053580. doi: 10.1155/2023/9053580. eCollection 2023. J Diabetes Res. 2023. PMID: 37187702 Free PMC article. Review.
-
The Effect of Selected Nitric Oxide Synthase Polymorphisms on the Risk of Developing Diabetic Nephropathy.Antioxidants (Basel). 2024 Jul 13;13(7):838. doi: 10.3390/antiox13070838. Antioxidants (Basel). 2024. PMID: 39061907 Free PMC article.
-
Association of Insertion/Deletion Polymorphisms of MDM2, MCP-1 and VEGF with Esophageal Cancer Risk in North-West Indians: A Case - Control Study.Asian Pac J Cancer Prev. 2025 May 1;26(5):1623-1631. doi: 10.31557/APJCP.2025.26.5.1623. Asian Pac J Cancer Prev. 2025. PMID: 40439374 Free PMC article.
-
Association of NOS3 (rs 2070744) and SOD2Val16Ala (rs4880) gene polymorphisms with increased risk of ESRD among Egyptian patients.J Genet Eng Biotechnol. 2021 Oct 18;19(1):158. doi: 10.1186/s43141-021-00260-w. J Genet Eng Biotechnol. 2021. PMID: 34661767 Free PMC article.
References
-
- Ahluwalia TS, Ahuja M, Rai TS, Kohli HS, Sud K, Bhansali A, Khullar M. Endothelial nitric oxide synthase gene haplotypes and diabetic nephropathy among Asian Indians. Mol Cell Biochem. 2008;314:9–17. - PubMed
-
- Ahluwalia TS, Khullar M, Ahuja M, Kohli HS, Bhansali A, Mohan V, Venkatesan R, Rai TS, Sud K, Singal PK. Common variants of inflammatory cytokine genes are associated with risk of nephropathy in type 2 diabetes among Asian Indians. PLoS ONE. 2009;4:e5168. doi: 10.1371/journal.pone.0005168. - DOI - PMC - PubMed
-
- Bagci B, Bagci G, Candan F, Ozdemir O, Sezgin I. The protective effect of MCP-1 -2518 A>G promoter polymorphism in Turkish chronic renal failure patients requiring long-term hemodialysis. Int Urol Nephrol. 2015;47:551–556. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous